HELX logo

HELX Overview

Profile

Name:

Franklin Genomic Advancements ETF

Assets under management:

$10 M

Expense ratio:

0.50%

Inception date:

February 27, 2020

Website:

-

Last ex-dividend date:

December 30, 2021

Next ex-dividend date:

N/A

Description:

The HELX ETF is an exchange-traded fund that focuses on companies involved in healthcare and biotechnology. It aims to provide investors with exposure to innovative healthcare solutions and advancements, offering potential growth opportunities in the rapidly evolving health sector.

Top holdings

Name
Weight
NTRA logo
Natera(NTRA)
5.81 %
4.61 %
VERTEX PHARMACEUTICALS INC(0QZU.L)
4.39 %
SAMSUNG BIOLOGICS CO LTD(207940.KS)
3.75 %
3.51 %
THERMO FISHER SCIENTIFIC INC(0R0H.L)
3.22 %
2.86 %
2.65 %
CTVA logo
Corteva(CTVA)
2.58 %
INSMED INC(0JAV.L)
2.49 %
SAREPTA THERAPEUTICS INC(0L35.L)
2.32 %
SARTORIUS AG VORZUG(SUVPF)
2.27 %
2.19 %
DHR logo
Danaher(DHR)
2.02 %
1.98 %
REVVITY INC(PKI)
1.93 %
CADENCE DESIGN SYS INC(0HS2.L)
1.82 %
1.80 %
1.53 %
1.51 %
RGEN logo
Repligen(RGEN)
1.41 %
LONZA GROUP AG REG(LZAGF)
1.33 %

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Technical Analysis

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend per share

Top holdings

Name
Weight
NTRA logo
Natera(NTRA)
5.81 %
4.61 %
VERTEX PHARMACEUTICALS INC(0QZU.L)
4.39 %
SAMSUNG BIOLOGICS CO LTD(207940.KS)
3.75 %
3.51 %
THERMO FISHER SCIENTIFIC INC(0R0H.L)
3.22 %
2.86 %
2.65 %
CTVA logo
Corteva(CTVA)
2.58 %
INSMED INC(0JAV.L)
2.49 %
SAREPTA THERAPEUTICS INC(0L35.L)
2.32 %
SARTORIUS AG VORZUG(SUVPF)
2.27 %
2.19 %
DHR logo
Danaher(DHR)
2.02 %
1.98 %
REVVITY INC(PKI)
1.93 %
CADENCE DESIGN SYS INC(0HS2.L)
1.82 %
1.80 %
1.53 %
1.51 %
RGEN logo
Repligen(RGEN)
1.41 %
LONZA GROUP AG REG(LZAGF)
1.33 %

Analyst ratings

FAQ

  • What is HELX?
  • Does HELX pay dividends?
  • What stocks are in HELX?
  • What is the current assets under management for HELX?
  • What is HELX average volume?
  • What is HELX expense ratio?
  • What is HELX inception date?

What is HELX?

The HELX ETF is an exchange-traded fund that focuses on companies involved in healthcare and biotechnology. It aims to provide investors with exposure to innovative healthcare solutions and advancements, offering potential growth opportunities in the rapidly evolving health sector.

Does HELX pay dividends?

Yes, the Franklin Genomic Advancements ETF does pays dividends, with the most recent payment being $0.00 per share. The last ex-dividend date was on December 30, 2021, and the next ex-dividend date has not been announced yet

What stocks are in HELX?

As of today, Franklin Genomic Advancements ETF inlcudes 71 holdings, with 45 of them being companies from 7 different countries and 3 sectors. The most weighted holdings are Natera (5.81%), Krystal Biotech (4.61%) and VERTEX PHARMACEUTICALS INC (4.39%)

What is the current assets under management for HELX?

Assets under management of Franklin Genomic Advancements ETF is $10 M

What is HELX average volume?

Average volume of Franklin Genomic Advancements ETF is $2512

What is HELX expense ratio?

Expense ratio of Franklin Genomic Advancements ETF is 0.50%

What is HELX inception date?

Inception date of Franklin Genomic Advancements ETF is February 27, 2020